Therapeutic efficacy of bacteriophage and baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers

Poultry Science

Volumn 83, Issue 12, 2004, Pages 1944-1947

  Huff, W E ^a   Huff, G R ^a   Rath, N C ^a   Balog, J M ^a   Donoghue, A M ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Bacteriophage; Chicken; Escherichia coli

Indexed keywords

AVES; ESCHERICHIA COLI; GALLUS GALLUS;

EID: 9744223697     PISSN: 00325791     EISSN: None     Source Type: Journal    
DOI: 10.1093/ps/83.12.1944     Document Type: Article

References (24)

1. Alisky, J., K. Iczkowski, A. Rapoport, and N. Troitsky. 1998. Bacteriophages show promise as antimicrobial agents. J. Infect. 36:5-15.
2. Barrow, P., M. Lovell, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:294-298.
3. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
4. Carlton, R. M. 1999. Phage therapy: Past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz.) 47:267-274.
5. d'Herelle, F. 1917. Sur un microbe invisible antagonists des bacilles dysenteriques. C. R. Acad. Sci. Paris. 165:373-375.
6. Goode, D. H., V. M. Allen, and P. A. Barrow. 2003. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophage. Appl. Environ. Microbiol. 69:5032-5036.
7. Huff, G. R., W. E. Huff, J. M. Balog, and N. C. Rath. 1998. The effects of dexamethasone immunosuppression on turkey osteomyelitis complex in an experimental Escherichia coli respiratory infection. Poult. Sci. 77:654-661.
8. Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2002a. Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poult. Sci. 81:1486-1491.
9. Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2003a. Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection. Poult. Sci. 82:1108-1112.
10. Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, and A. M. Donoghue. 2003b. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis. 47:1399-1405.
11. Huff, W. E., G. R. Huff, N. C. Rath, J. M. Balog, H. Xie, P. A. Moore, Jr., and A. M. Donoghue. 2002b. Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage (SPR02). Poult. Sci. 81:437-441.
12. Leverentz, B., W. S. Conway, M. J. Camp, W. J. Janisiewicz, T. Abuladze, M. Yang, R. Saftner, and A. Sulakvelidze. 2003. Biocontrol of Listeria moncytogenes on fresh-cut produce by treatment with lytic bacteriophage and a bacteriocin. Appl. Environ. Microbiol. 69:4519-4526.
13. SAS/STAT User's Guide. 1998 SAS Institute Inc., Cary, NC.
14. Ślopek, S., I. Durlakowa, B. Weber-Da̧browska, M. Da̧browski, and A. Kucharewicz Krukowska. 1984. Results of bacteriophage treatment of suppurative bacterial infections: III. Detailed evaluation of the results obtained in further 150 cases. Arch. Immunol. Therap. Exp. 32:317-335.
15. Ślopek, S., I. Durlakowa, B. Weber-Da̧browska, M. Ḑbrowski, and A. Kucharewicz-Krukowska. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp. 35:569-583.
16. Ślopek, S., I. Durlakowa, B. Weber-Da̧browska, A. Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz. 1981. Results of bacteriophage treatment of suppurative bacterial infections: II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp. 31:293-327.
17. Ślopek, S., A. Kucharewicz-Krukowska, B. Weber-Dabrowska, and M. Dabrowski. 1985. Results of bactiophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. 33:261-273.
18. Smith, H. W., and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: Its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
19. Smith, H. W., and M. B. Huggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
20. Smith, H. W., M. B. Huggins, and K. M. Shaw. 1987. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J. Gen. Microbiol. 133:1111-1126.
21. Snedecor, G. W., and W. G. Cochran. 1967. Pages 258-380 in Statistical Methods. 6th ed. Iowa State University Press, Ames, IA.
22. Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 37:258-261.
23. Twort, F. W. 1915. An investigation on the nature of ultramicroscopic viruses. Lancet 2:1241-1243.
24. Weber-Da̧browska, B., M. Da̧browski, and S. Ślopek. 1987. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35:563-568.